Staff Reporter 

Local resident among those who benefited from monoclonal antibodies treatment for COVID-19


November 18, 2021

WORLAND – An emergency use authorization treatment for COVID-19 proved beneficial for one local resident.

When the COVID-19 pandemic first began in the spring of 2020, no specific treatment for the virus existed. Since then, however, the Food and Drug Association (FDA) has granted Emergency Use Authorization (EUA) to several monoclonal antibody therapies as treatments for COVID-19.

Monoclonal anti...

For access to this article please sign in or subscribe.


Powered by ROAR Online Publication Software from Lions Light Corporation
© Copyright 2024